The U.S. Food and Drug Administration (FDA) has issued a recall for a pharmaceutical product after identifying deviations from current Good Manufacturing Practices (CGMP). The recall underscores the agency's focus on ensuring manufacturing compliance and product safety.
規制動向2026年8月24日•1分で読めます
FDA Recalls Product Due to CGMP Deviations
The FDA has initiated a recall of a product because of deviations from current Good Manufacturing Practices (CGMP).
PharmaCountryチームがまとめました · 出典： FDA.gov
評価
(0)
(0)
(0)
(0)
(0)
評価を残す